Prospective Study
Copyright ©The Author(s) 2024.
World J Diabetes. Apr 15, 2024; 15(4): 712-723
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.712
Table 6 Sensitivity analysis of remnant cholesterol and all-cause and cardiovascular mortality after adjusting for lipid-lowering drug and anti-hypertensive drug
Hazard ratio (95%CI)

Q1
Q2
Q3
Q4
Per SD
P value
All-cause mortality
Model 6Reference1.08 (0.70-1.65)0.65 (0.41-1.03)0.98 (0.66-1.47)1.37 (1.13-1.65)0.05